• NewAmsterdam Pharma granted 71,800 inducement share options to seven non-executive new hires under its 2024 Inducement Plan.
• Options carry an exercise price of $24.16 per share, set at the Oct. 1 Nasdaq closing price.
• Option awards vest over four years, with 25% after one year, then 36 equal monthly installments.
• Separate inducement grants issued 17,745 restricted stock units to the same seven hires on Oct. 1.
• Restricted stock units vest over three years in equal annual tranches, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021601PRIMZONEFULLFEED9838716) on October 02, 2026, and is solely responsible for the information contained therein.